Out Fox The $treet

As investors were warned,  Rite Aid (RAD)  was only going to head lower following the 1-for-20 reverse split. The company provided the following financial targets for FY20: Sales to be between $21.5 billion and $21.9 billion in fiscal 2020  Same store sales expected to range from an increase of 0.0 percent to an increase of 1.0 percent over fiscal 2019. Net loss is expected to be between $170.0 million and $220.0 million.   Adjusted EBITDA is expected to be between $500.0 million and $560.0 million.   Adjusted net (loss) income per share is expected to be between a loss of $0.01 and income of $0.04. These are not the numbers investors want to see in a competitive environment where  Walgreens (WBA)  and  CVS Health (CVS)  are already dealing with competitive impacts from  Amazon (AMZN)  entering the pharmacy space. The likelihood of Rite Aid recovering isn't very high. Avoid or short the stock that k...

Typically, a reverse merger is a sign of a company facing troubling finances, though I'll be the first person to tell investors that this isn't always the case. Each stock in the process of a reverse merger needs the merits of its individual case reviewed by an investor. In the case of Rite Aid (RAD) and Novavax (NVAX) ,  these reverse mergers are signs that these stocks face incredibly difficult times ahead and the stocks are likely headed even lower. Rite Aid got approval by shareholders for a reverse split that needs to happen by the end of June to cure NYSE requirements for a $1 listing. At $0.57, the stock would trade at $11.40 on a 1:20 split to take place on April 22. The problem is that Rite Aid continues to face more pressure from Amazon in the pharmacy space and stronger competitors that are already struggling. At a pric...

Following the announcement of a planned reverse split, Rite Aid (RAD) continues to fall further below $1. The company now needs to complete a 1-20 split in order to get the stock to $15 post split.

After the close, Rite Aid (RAD) announced the intent to vote on a reverse split at a special meeting on March 21. The stock trades below $1 and the company needs to regain compliance with the NYSE so the move isn't surprising.